CytoDyn sees impressive results with Leronlimab on very ill COVID-19 patients
CytoDyn (OTCQB: CYDY) CEO Dr Nader Pourhassan and IncellDX CEO Dr Bruce Patterson joined Steve Darling from Proactive Vancouver with news that the three-day effect of leronlimab in eight severely ill COVID-19 patients demonstrated a significant improvement in several important immunologic biomarkers.
Both Dr Patterson and DR Pourhassen tell Proactive about the study and the next major steps they are planning on taking.
Видео CytoDyn sees impressive results with Leronlimab on very ill COVID-19 patients канала Proactive
Both Dr Patterson and DR Pourhassen tell Proactive about the study and the next major steps they are planning on taking.
Видео CytoDyn sees impressive results with Leronlimab on very ill COVID-19 patients канала Proactive
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Assessing Clinical Trials For Possible COVID-19 TreatmentThe burden of being the only son | Pema Gurung | TEDxSaxionUniversityWhy We Might Not Need A Vaccine for COVID-19 | This MorningCovid 19 antibodies breakthrough made in San FranciscoMayo Clinic vaccinologist discusses COVID-19 vaccine developmentCNBC's full interview with 3M CEO on Pres. Donald Trump's tweet, price gauging and moreWe bought our Merry Fisher 695Arizona Silver Exploration update progress on drilling program at Philadelphia ProjectBIOLASE 'back to pre-pandemic revenue levels' after reporting 2021 and fourth quarter resultsAlien Metals Ltd CEO, Bill Brodie Good presenting at the One2One Forum 7th April 2022Central Asia Metals PLC, CFO Gavin Ferrar presenting at the One2One Forum 7th April 2022How Traders Use Market Manipulation To Profit (TSLA)Tuesday 21 April, International UpdateThe Pathology of Long Covid - Why Viral Debris May Be The Cause | With Dr Bruce PattersonHIV and flu -- the vaccine strategy - Seth BerkleyLearn Ichimoku Kinko Hyo In Under 30 MinutesUnderstanding The Coronavirus— Infectious Disease Expert Dr. Otto Yang Explains Fact From FictionOrtho Regenerative Technologies closes oversubscribed non-brokered private placement for $3.2MSPYR Technologies' Applied Magix planning digital marketing push, Secret Lab initiativesEndexx talks potential OTCQB up-list, 2021 and fourth quarter financials, growth plans